These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35099407)

  • 1. Effect of TSH levels during active surveillance of PTMC according to age.
    Kim HI; Jin M; Ko NG; Oh YL; Shin JH; Kim JH; Kim JS; Jeon MJ; Kim TY; Kim SW; Kim WB; Chung JH; Shong YK; Kim WG; Kim TH
    Endocr Relat Cancer; 2022 Mar; 29(4):191-200. PubMed ID: 35099407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.
    Kim HI; Jang HW; Ahn HS; Ahn S; Park SY; Oh YL; Hahn SY; Shin JH; Kim JH; Kim JS; Chung JH; Kim TH; Kim SW
    J Clin Endocrinol Metab; 2018 Feb; 103(2):446-451. PubMed ID: 29211863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.
    Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
    Thyroid; 2023 Oct; 33(10):1182-1189. PubMed ID: 37310904
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid-Stimulating Hormone, Age, and Tumor Size are Risk Factors for Progression During Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma in Adults.
    Ito Y; Miyauchi A; Fujishima M; Noda T; Sano T; Sasaki T; Kishi T; Nakamura T
    World J Surg; 2023 Feb; 47(2):392-401. PubMed ID: 36182976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.
    Ito Y; Miyauchi A; Kihara M; Higashiyama T; Kobayashi K; Miya A
    Thyroid; 2014 Jan; 24(1):27-34. PubMed ID: 24001104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between preoperative serum TSH and tumor status in patients with papillary thyroid microcarcinoma.
    Mao A; An N; Wang J; Wu Y; Wang T; Wang Z; Guan H; Wang J
    Endocrine; 2021 Sep; 73(3):617-624. PubMed ID: 33755880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
    Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
    Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
    Jin M; Kim HI; Ha J; Jeon MJ; Kim WG; Lim DJ; Kim TY; Chung JH; Shong YK; Kim TH; Kim WB
    Thyroid; 2021 Oct; 31(10):1494-1501. PubMed ID: 34225475
    [No Abstract]   [Full Text] [Related]  

  • 9. Computed Tomography for Detecting Cervical Lymph Node Metastasis in Patients Who Have Papillary Thyroid Microcarcinoma with Tumor Characteristics Appropriate for Active Surveillance.
    Lee DH; Kim YK; Yu HW; Choi JY; Park SY; Moon JH
    Thyroid; 2019 Nov; 29(11):1653-1659. PubMed ID: 31436140
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relationship between serum thyroxin-stimulating hormone and papillary thyroid micrcarcinoma in nodular thyroid disease].
    Jiao J; Zhou Y
    Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(12):908-11. PubMed ID: 26081052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.
    Gao Y; Qu N; Zhang L; Chen JY; Ji QH
    Tumour Biol; 2016 Jun; 37(6):7453-9. PubMed ID: 26678888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma.
    Choi JS; Kim EK; Moon HJ; Kwak JY
    Endocrine; 2015 Feb; 48(1):264-71. PubMed ID: 24858734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
    Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
    Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
    [No Abstract]   [Full Text] [Related]  

  • 14. Papillary thyroid microcarcinoma might progress during pregnancy.
    Shindo H; Amino N; Ito Y; Kihara M; Kobayashi K; Miya A; Hirokawa M; Miyauchi A
    Thyroid; 2014 May; 24(5):840-4. PubMed ID: 24397849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma.
    Moon JH; Ryu CH; Cho SW; Choi JY; Chung EJ; Hah JH; Hwangbo Y; Jeong WJ; Jung YS; Kim JH; Kim MJ; Kim SJ; Kim YK; Lee CY; Lee EK; Lee JY; Lee KE; Lee YJ; Lee Y; Yu HW; Park DJ; Ryu J; Park YJ
    J Clin Endocrinol Metab; 2021 Mar; 106(3):724-735. PubMed ID: 33248442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
    Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
    Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
    Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
    [No Abstract]   [Full Text] [Related]  

  • 18. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
    Kwon H; Oh HS; Kim M; Park S; Jeon MJ; Kim WG; Kim WB; Shong YK; Song DE; Baek JH; Chung KW; Kim TY
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1917-1925. PubMed ID: 28323932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study.
    Kim K; Choi JY; Kim SJ; Lee EK; Lee YK; Ryu JS; Lee KE; Moon JH; Park YJ; Cho SW; Park SK
    Thyroid; 2022 Jun; 32(6):648-656. PubMed ID: 35570657
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical features and therapeutic outcomes of patients with papillary thyroid microcarcinomas and larger tumors.
    Zheng W; Wang X; Rui Z; Wang Y; Meng Z; Wang R
    Nucl Med Commun; 2019 May; 40(5):477-483. PubMed ID: 30973839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.